SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-19-185998
Filing Date
2019-06-28
Accepted
2019-06-28 16:08:03
Documents
7
Effectiveness Date
2019-06-28

Document Format Files

Seq Description Document Type Size
1 S-8 d768362ds8.htm S-8 72879
2 EX-5.1 d768362dex51.htm EX-5.1 6719
3 EX-23.1 d768362dex231.htm EX-23.1 1577
4 EX-99.3 d768362dex993.htm EX-99.3 22148
5 GRAPHIC g768362g67e87.jpg GRAPHIC 5321
6 GRAPHIC g768362g70g90.jpg GRAPHIC 2886
7 GRAPHIC g768362g74k65.jpg GRAPHIC 4160
  Complete submission text file 0001193125-19-185998.txt   121910
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Novus Therapeutics, Inc. (Filer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-232428 | Film No.: 19929309
SIC: 2834 Pharmaceutical Preparations